BCOP Preparatory and Recertification Course

The HOPA Preparatory and Recertification Course is designed to prepare oncology pharmacists to sit for the BCOP Certification Exam.

The HOPA Recertification Course assists current oncology pharmacists in meeting the BPS requirement to complete a Preparatory Review/Recertification Course at least once, but no more than three times, in nonconsecutive years, during their 7-year BCOP recertification cycle.

The HOPA Preparatory and Recertification Course offers 28 hours of BCOP recertification credit and is available on demand. The course consists of content outlines in addition to webinars.

Both the BCOP Preparatory course and the BCOP Recertification course are available now.

bcop infographic updt


The HOPA Preparatory Course and the HOPA Recertification Course is divided into 6 parts as shown below. Each features a content outline. Those taking the Recertification course are eligible for BCOP credit. Click on each topic to learn more.

Part I (5.5 hours)

Part II (5.5 hours)

Part III (6 hours)

Part IV (5.5 hours)

Part V (5.5 hours)

Part VI (5.5 hours)

*ACPE credit only



self study icon Self Study Outline

Webinar icon Webinar


If you are preparing to sit for the BCOP Certification Exam and want to take the Preparatory Course for ACPE credit, click here:

Order BCOP Preparatory Course Now

If you are already BCOP certified and want to take the Recertification Course for BCOP and ACPE credit, click here:

Order BCOP Recertification Course Now

Credit Designation

Accreditation Statement:

logo acpeThe Hematology/Oncology Pharmacy Association (HOPA) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. An ACPE statement of credit will be issued only upon completion of the pre/post- assessment and a post-activity evaluation form. ACPE credit must be claimed by June 30, 2023.

education speaker bpslogo The Hematology/Oncology Pharmacy Association (HOPA) is accredited by the Board of Pharmacy Specialties (BPS) as a provider of Board Certified Oncology Pharmacist (BCOP) credit. A BCOP statement of credit will be issued only upon completion of a post-activity evaluation form, and post-test, with a combined passing grade of 75% or greater is achieved. Tests must be completed by June 30, 2023.

Disclosure of Conflicts of Interest: The Hematology/Oncology Pharmacy Association (HOPA) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CE activities. All relevant conflicts of interest that are identified are thoroughly vetted by HOPA for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. HOPA is committed to providing its learners with high-quality CE activities and related materials that promote improvements of quality in healthcare and not a specific proprietary business interest of a commercial interest.

Reported Areas of Conflict: Planners and Managers Hematology/Oncology Pharmacy Association does not view the existence of relationships as an implication of bias or that the value of the material is decreased. The content of the activity was planned to be balanced, objective, and scientifically rigorous. Occasionally, authors may express opinions that represent their own viewpoint. Conclusions drawn by participants should be derived from objective analysis of scientific data. Unlabeled/unapproved uses of drugs. All faculty have indicated that they have not referenced unlabeled/unapproved uses of drugs and devices.

For more information about BCOP certification and recertification, click here.